Jenoptik signs €30m deal to develop microscopy imaging system

Share this on social media:

Jenoptik signs long-term agreement to develop and produce microscopy imaging instrument with leading life science company based on the technology platform JENOPTIK SYIONS. The scope of the agreement is anticipated to exceed 30 million euros for the coming years.

The SYIONS system allows customers to take advantage of a range of imaging technologies and predefined modules to reduce time-to-market. Combining partially standardized optical, opto-mechanical and electronic modules with powerful imaging and control software enables easy integration into existing instruments or completely new developments. The versatile, miniaturized platform can be adapted to a variety of bio-imaging applications to increase productivity in scientific and clinical laboratories.

“With SYIONS, Jenoptik is focusing its extensive expertise in digital imaging on the fast growing biophotonics market, and we are very excited about this partnership with a leading company in the global life sciences market,” said Dr. Stefan Traeger, President and CEO of Jenoptik.

Leica Biosystems' Aperio GT 450 DX is designed for high-volume clinical labs to scale up digital pathology operations. Credit: Leica Biosystems

21 December 2021

Imec researchers on-board the parabolic flight. Credit Imec

12 January 2022

Leica Biosystems' Aperio GT 450 DX is designed for high-volume clinical labs to scale up digital pathology operations. Credit: Leica Biosystems

21 December 2021

Six images at relevant wavelengths to differentiate tumour cells. Credit: CEA-Leti

18 March 2021